Think Outside the Eye
Skin and eyelid inflammation affects millions of Americans every year. Over 85% of skin and eyelid inflammation patients also suffer from inflammatory ocular conditions, such as Meibomian Gland Dysfunction (MGD), blepharitis, eyelid inflammation and eyelid telangiectasia1.
Lumenis invites you to think outside the eye and offer your patients a solution to their skin inflammation and skin related problems with M22™. M22™ combines Intense Pulsed Light (IPL) with unique Optimal Pulse Technology (OPT™), and is FDA cleared for 20 different skin indications, including rosacea treatment and other skin inflammatory conditions2.